Gatifloxacin-containing regimens cost saving in CAP

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1417, 2003-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levofloxacin-containing critical pathway for CAP cost saving

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 260, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Gatifloxacin a cost-effective alternative for CAP

By  

Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Critical pathway cost saving for CAP management

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 250, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Gatifloxacin

By Perry C.M.   Barman Balfour J.A.   Lamb H.M.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 683-696

Adis International

Access to resources Recommend Favorite

Cost Analysis of 2 Empiric Antibacterial Regimens Containing Glycopeptides for the Treatment of Febrile Neutropenia in Patients with Acute Leukaemia

By Bucaneve G.  

PharmacoEconomics, Vol. 15, Iss. 1, 1999-01 ,pp. : 85-95

Adis International

Access to resources Recommend Favorite